(Total Views: 836)
Posted On: 11/30/2020 8:10:47 AM
Post# of 50
$VSTM News Article - Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer https://marketwirenews.com/news-releases/vera...85465.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
